Table 2 Peak HR, blood pressure and RPP during DSE in IS and IR groups
From: Hyperinsulinemia improves ischemic LV function in insulin resistant subjects
| Â | Â | Insulin Sensitive | Insulin Resistant | ||||
|---|---|---|---|---|---|---|---|
| Â | Â | Control | Clamp | p | Control | Clamp | p |
Max Dobutamine dose (μg/kg/min) | 37.5 (4.5) | 38.3 (3.9) | ns | 35.8 (5.1) | 35 (5.2) | ns | |
Mean Atropine dose (μg) | 150 (239) | 150 (239) |  | 100 (233) | 100 (233) |  | |
Hemodynamic variables | Â | Â | Â | Â | Â | Â | |
Mean %max HR achieved | 83 (8) | 83 (5) | ns | 81 (7) | 80 (9) | ns | |
Peak | HR (bpm) | 130 (15) | 130 (10) | ns | 126 (10) | 124 (13) | ns |
| Â | SBP (mmHg) | 147 (21) | 143 (20) | ns | 142 (25) | 141 (25) | ns |
| Â | RPP (bpm.mmHg) | 19026 (2850) | 18554 (2925) | ns | 17897 (3298) | 17540 (3979) | ns |